Curcumin for Cognitive Function

Verdict: Weak, conflicting evidence for cognition

Curcumin shows only weak, inconsistent evidence for supporting cognitive function: any benefit appears limited to specific domains like working memory in older adults using high-bioavailability formulations, and major health authorities agree the evidence is too thin to recommend it for memory or brain health.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is held to weak (C) because the strongest evidence directly contradicts itself. Two 2025 meta-analyses split on the core outcome of global cognition: Wang 2025 (PMID 40308636, 9 RCTs, n=501) found a significant benefit (SMD 0.82, 95% CI 0.19-1.45), but a cognitive-aging meta-analysis the same year (PMID 40579315, n=531) found no global effect (SMD 0.14, 95% CI -0.78 to 1.07). With one positive and one null high-tier source, neither dominates.

What signal exists is narrow and conditional. The null meta-analysis still found benefits for working memory (SMD 1.01) and processing speed (SMD 0.37), echoed by small RCTs in older adults using bioavailable formulations (Small 2018, PMID 29246725, Theracurmin; Cox 2020, PMID 32512782, Longvida working memory). Effects appear only at sufficient duration, age 60+, and with specialized formulations, not generic supplements or younger users. Notably, three of five studies were funded by formulation manufacturers, flagging industry-bias risk.

Health authorities reinforce caution rather than endorsement. NIH's NCCIH states plainly, 'We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes,' and Cleveland Clinic says 'more research is needed,' while Mayo Clinic and Harvard Health do not address cognition at all. EFSA rejected curcumin health claims and set a 3 mg/kg/day intake limit, and NHS Wales warns against use with liver or biliary disease, given documented liver-injury reports.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.45
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
81%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L5 Clinical bodiesAuthoritative stance
0.49
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.446
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

PMID: 29246725 2018 隨機對照試驗 n = 40
Finding: Significant improvement in memory (SCAVLT consolidation) and attention vs placebo over 18 months; FDDNP-PET imaging showed decreased amyloid/tau binding in amygdala and hypothalamus. Key reference trial demonstrating that bioavailable curcumin may benefit memory in non-demented older adults.
⚠️ Industry-funded
View on PubMed
PMID: 32512782 2020 隨機對照試驗 n = 80
Finding: Significant improvement in working memory at 12 weeks and reductions in fatigue/total mood disturbance vs placebo. Partial replication of earlier Cox 2015 findings. No significant effect on global cognition.
⚠️ Industry-funded
View on PubMed
PMID: 2023 隨機對照試驗 n = 48
— See PubMed for details
View on PubMed
PMID: 40308636 2025 統合分析 n = 501
Finding: Pooled 9 RCTs (12 comparisons): curcumin significantly improved global cognitive function vs placebo (SMD 0.82, 95% CI 0.19-1.45, p=0.010). Subgroup effects significant only when duration >=24 weeks, age >=60, or Asian populations. Curvilinear dose-response.
Academic Effect size: [object Object]
View on PubMed
PMID: 40579315 2025 統合分析 n = 531
Finding: No significant effect on global cognition (SMD 0.14, 95% CI -0.78 to 1.07). Domain-specific benefits: working memory (SMD 1.01, 95% CI 0.15-1.87) and processing speed (SMD 0.37, 95% CI 0.07-0.67) significant. Adverse events numerically higher in curcumin arms. Confirms mixed/cautious evidence picture.
Academic Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4b EU EFSA
Cautious
the Panel established an ADI for curcumin of 3 mg/kg bw/day source↗
L4c UK NHS
Cautious
Avoid turmeric and curcumin in individuals with bile duct obstruction, cholangitis, liver disease, gallstones, or any biliary disease. source↗
L4d TW TFDA / 衛福部
Cautious
薑黃素每人每日攝取量為每公斤體重0~3毫克,每日不超過200毫克為宜 source↗
L4e WHO
Neutral
Rhizoma Curcumae Longae source↗
L5a NIH Office of Dietary Supplements
Cautious
We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes. source↗
L5c Cleveland Clinic
Cautious
more research is needed source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-curcumin-001 繁體中文版 →